Interview with Mohammad Afshar – CEO, Ariana Pharma, France, 12 July 2016 (more…)

The WIN 2016 Symposium is the place to be to learn about the latest in cancer research by world class presenters. Come and meet the Ariana team of Dr Mohammad Afshar, Dr Guergova-Kuras, Dr Morley and Dr Vaucouleur.

Come and meet our CEO Dr Afshar, and Director of Sales Dan Manak, at BIO 2016 for the latest on the KEM® portal!

Ariana Pharma and Laboratoires Pierre Fabre have recently published the results of a clinical data mining study using KEM to identify best responder subgroups for Milnacipran in fibromyalgia. (more…)

Ariana hosted their regular Science Day this week - a 1-day symposium in Paris on advances in machine learning and artificial intelligence, chaired by Dr Jean Sallantin, Director of Research at the CNRS LIRMM (Laboratoire d’Informatique, de Robotique et de Micro-électronique de Montpellier) and Scientific Advisor to Ariana. (more…)

The Ariana Running Team are pleased to participate in the popular NoFinishLine Paris 2016 charitable fun run event in support of sick and homeless children. (more…)

Dr Miralves and Dr Vaucouleur from Ariana Pharma will present their latest accomplishments in tool development for the deployment of data-driven algorithms for personalized medicine at the Sanofi France R&D Science Days event.

Our CEO, Dr Mohammad Afshar, will present at Biomarker Summit 2016 on the challenge of transforming biomarker data into clinically actionable information for personalized cancer treatment selection. (more…)

Dr Afshar and the Ariana team will discuss the use of a broad range of data extracted from hospital records and their impact on personalized medicine at Données de santé hospitalières en Europe : nouvelles perspectives pour la recherche clinique et l'innovation (more…)

Our CTO, Dr Mariana Guergova-Kuras, joins a distinguished panel of speakers at UCD/Breast-Predict event focused on prognostic and predictive tools. (more…)